NATtrol

qPCR Controls for NAT
NatTrol
GenExpert Cepheid
Idnow Abbott
Luminex® Aries®
Luminex® MAGPIX®
Luminex® VERIGENE®
NATtrol AdV/hMPV/HRV qPCR control (6 X 0.5 mL) NATAMR-ERC
NATtrol B. pertussis/parapertussis Positive qPCR control (6 X 0.25 mL) NATBRD-6L
NATtrol Flu Verification qPCR quality Panel (7 X 0.5 Ml) NATFVP-NNS
NATtrol Flu Verification qPCR quality Panel (7 X 0.5 mL) NATFVP-NNS
NATtrol Flu/RSV/SARS-CoV-2 Negative qPCR control (6 x 0.5mL) NATCV9-6C
NATtrol Flu/RSV/SARS-CoV-2 Positive qPCR control (6 x 0.5mL) NATFRC-6C
NATtrol Influenza A H1 Virus Stock (Qualitative) (1 mL) NATFLUAH1-ST
NATtrol Influenza A H1, External Run qPCR control, Low (6 X 1.0 mL) NATFLUAH1-ERCL
NATtrol Influenza A H1, External Run qPCR control, Medium (6 X 1.0 mL) NATFLUAH1-ERCM
NATtrol Influenza A H1N1 Positive qPCR control (6 x 0.5 mL) NATFLUAH1N1-6MC
NATtrol Influenza A H1N1, External Run qPCR control, Medium (6 X 1.0 mL) NATFLUAH1N1-ERCM
NATtrol Influenza A H3 Virus Stock (Qualitative) (1 mL) NATFLUAH3-ST
NATtrol Influenza A/B Positive qPCR control (6 x 0.5 mL) MDZ046
NATtrol Influenza A/B Positive qPCR control (6 x 0.5 mL) NATFLUA/B-6MC
NATtrol Influenza A/B Positive qPCR control (6 x 0.5 mL) NATFLUAB-6C
NATtrol Influenza A/B Positive qPCR control (6 X 0.5mL) NATFLUAB-6C
NATtrol Influenza B Virus Stock (Qualitative) (1 mL) NATFLUB-ST
NATtrol Influenza B, External Run qPCR control, Low (6 X 1.0 mL) NATFLUB-ERCL
NATtrol Influenza B, External Run qPCR control, Medium (6 X 1.0 mL) NATFLUB-ERCM
NATtrol Influenza Negative qPCR control (6 x 0.5 mL) NATCXVA9-6MC
NATtrol Influenza Verification qPCR quality Panel (18 x 0.5 mL) NATFVP(XP)-C
NATtrol Influenza/RSV Negative qPCR control (6 x 0.5 mL) MDZ045
NATtrol Influenza/RSV Negative qPCR control (6 x 0.5 mL) NATCXVA9-6C
NATtrol Influenza/RSV Positive qPCR control (6 x 0.25 mL) NATFLURSV-6L
NATtrol Influenza/RSV Positive qPCR control (6 x 0.5 mL) NATFLURSV-6C
NATtrol Influenza/RSV Verification qPCR quality Panel (21 x 0.5 mL) NATFRVP-C
NATtrol InfluenzaA H1N1, External Run qPCR control, Low (6 X 1.0 mL) NATFLUAH1N1-ERCL
NATtrol Parainfluenza qPCR control (6 X 0.5 mL) NATPIV-ERC
NATtrol Parainfluenza Virus Type 1 Stock (Qualitative) (1 mL) NATPARA1-ST
NATtrol Parainfluenza Virus Type 2 Stock (Qualitative) (1 mL) NATPARA2-ST
NATtrol Parainfluenza Virus Type 3 Stock (Qualitative) (1 mL) NATPARA3-ST
NATtrol Parainfluenza Virus Type 4 Stock (Qualitative) (1 mL) NATPARA4-ST
NATtrol Pneumonia qPCR quality Panel-Atypical Bacteria & Viruses (12 x 0.2 mL; 2 x 1.2 mL) NATPPA-BIO
NATtrol Pneumonia qPCR quality Panel-Quantifiable Bacteria (17 x 0.2 mL; 3 x 1.2 mL) NATPPQ-BIO
NATtrol Respiratory qPCR quality Panel 2 (RP2) qPCR controls (12 x 0.3 mL) NATRPC2-BIO
NATtrol Respiratory qPCR quality Panel 2 (RP2) qPCR controls (EA) NATRPC2-BIO
NATtrol Respiratory Pathogen qPCR quality Panel-1 (6 x 0.25 mL) NATRPP-1
NATtrol Respiratory Syncytial Virus (RSV) Type A Stock (Qualitative) (1 mL) NATRSVA-ST
NATtrol Respiratory Syncytial Virus (RSV) Type B Stock (Qualitative) (1 mL) NATRSVB-ST
NATtrol Respiratory Validation qPCR quality Panel (RVP) (Qualitative) (13 X 0.2 mL) NATRVP-1
NATtrol Respiratory Validation qPCR quality Panel (RVP) (Qualitative) (17 X 0.2 mL) NATRVP-3
NATtrol Respiratory Verification qPCR quality Panel (15 x 0.5 mL; 2 x 1.0 mL) NATRVP-NNS
NATtrol Respiratory Verification qPCR quality Panel (20 X 0.2 mL) NATRVP-GMK
NATtrol Respiratory Verification qPCR quality Panel (20 X 0.25 mL) NATRVP-QIA
NATtrol Respiratory Verification qPCR quality Panel (RVP) (20 X 0.6 mL) NATRVP-IDI
NATtrol Respiratory Verification qPCR quality Panel 2 (23 x 0.6 mL) NATRVP2-BIO
NATtrol Respiratory Verification qPCR quality Panel 2.1 (24 x 0.6mL) (EA) NATRVP2.1-BIO
NATtrol RP qPCR controls (12 x 0.25 mL) NATRPC-NNS
NATtrol RP Multimarker qPCR controls (6 X 0.75 mL) MDZ001
NATtrol RSV Positive qPCR control (6 x 0.5 mL) MDZ047
NATtrol RSV Positive qPCR control (6 x 0.5 mL) NATRSV-6C
Respiratory qPCR controls and Verification qPCR quality Panels
qPCR qPCR controls foron the BioFire™ FilmArray® Platform:
qPCR qPCR controls foron the Cepheid® GeneXpert® Platform:
qPCR qPCR controls foron the Focus Simplexa™ Platform:
qPCR qPCR controls foron the Luminex® Platforms:
qPCR qPCR controls foron the Roche cobas® Liat® Platform:
qPCR qPCR controls for performance on our in-house real time PCR assays:
qPCR qPCR controls for performance on the Hologic ®Panter Fusion Platform:
qPCR qPCR controls for the GenMark® ePlex® Platform:
qPCR qPCR controls for the QIAGEN® QIAstat-Dx Platform:
qPCR qPCR controls for the Quidel® Sofia® Platform:
qPCR qPCR controls for on the Abbott ID NOW™ Platform:

https://gentaur.bg/nattrol-gi-controls-12-x-0-2-ml/no/3992272

Epitope and Paratope Mapping by HDX-MS Combined with SPR Elucidates the Difference in Bactericidal Activity of Two Anti-NadA Monoclonal Antibodies

Epitope and Paratope Mapping by HDX-MS Combined with SPR Elucidates the Difference in Bactericidal Activity of Two Anti-NadA Monoclonal Antibodies

Characterization of antigen-antibody interactions is essential for understanding antibody-mediated safety towards pathogens, biopharmaceutical growth, in addition to analysis of the immune response put up vaccination. Bexsero is a multicomponent vaccine towards Neisseria meningitidis serogroup B through which one of many key vaccine antigens is Neisserial adhesin A (NadA), a trimeric coiled-coil protein. Two NadA-specific monoclonal antibodies (mAbs) …

Epitope and Paratope Mapping by HDX-MS Combined with SPR Elucidates the Difference in Bactericidal Activity of Two Anti-NadA Monoclonal Antibodies Read More »

Rational Design of a Pan-Coronavirus Vaccine Based on Conserved CTL Epitopes

Rational Design of a Pan-Coronavirus Vaccine Based on Conserved CTL Epitopes

With the speedy international unfold of the Coronavirus Illness 2019 (COVID-19) pandemic, a protected and efficient vaccine in opposition to human coronaviruses (HCoVs) is believed to be a prime precedence within the subject of public well being. As a result of frequent outbreaks of various HCoVs, the event of a pan-HCoVs vaccine is of nice …

Rational Design of a Pan-Coronavirus Vaccine Based on Conserved CTL Epitopes Read More »

Immunoinformatics analysis to design novel epitope based vaccine candidate targeting the glycoprotein and nucleoprotein of Lassa mammarenavirus (LASMV) using strains from Nigeria

Immunoinformatics analysis to design novel epitope based vaccine candidate targeting the glycoprotein and nucleoprotein of Lassa mammarenavirus (LASMV) using strains from Nigeria

Lassa mammarenavirus (LASMV) is answerable for a particular sort of acute viral hemorrhagic fever generally known as Lassa fever. Lack of efficient therapies and counter-measures towards the virus has resulted in a excessive mortality fee in its endemic areas. Subsequently, on this research, a novel epitope-based vaccine has been designed utilizing the strategies of immunoinformatics …

Immunoinformatics analysis to design novel epitope based vaccine candidate targeting the glycoprotein and nucleoprotein of Lassa mammarenavirus (LASMV) using strains from Nigeria Read More »

Development of multi-epitope peptide-based vaccines against SARS-CoV-2

Development of multi-epitope peptide-based vaccines against SARS-CoV-2

Extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has precipitated a pandemic involving so excess of 32 million infections and 980,031 deaths. Efficient vaccines are urgently wanted to stop SARS-CoV-2 infections. No vaccines have but been accepted for licensure by regulatory businesses. Although host immune responses to SARS-CoV-2 infections are starting to be unravelled, efficient clearance …

Development of multi-epitope peptide-based vaccines against SARS-CoV-2 Read More »